I, Cyborg

[Serb]

Glad to hear you are okay. Are you connected to Skynet yet?

I am always have been!

[Serb]

And if you a fan, you should know it were Russians who had destroyed America in a Skynet universe.

[Broken_Erika]

They Destroyed eachother.

[PLATO]

Yep. AI is something to think about for both nations. If you look at things that are internationally banned, like Chemical weapons, I think independent military AI should be internationally banned as well.

[Serb]

I am very glad serb is well and hoping evyerine is well

however I can't let this go unanwered.

such operations and even far more compicated operations are compeltely free in Greece ( and I'd lie to think in many other euopean countries too)

they might not be free in some other so called developed countries

and that is why we are fighting

I hope even the most hard core greek right winger acknowledges that this is correct and should be defended

nevermind his stupidity in votring

http://Methods and Results—Healthcare resource use was collected prospectively on the first 430 patients enrolled in CIDS (n=212 ICD, n=218 amiodarone). Mean cost per patient, adjusted for censoring, was computed for each group based on initial therapy assignment. Incremental cost-effectiveness of ICD therapy was computed as the ratio of the difference in cost (ICD minus amiodarone) to the difference in life expectancy (both discounted at 3% per year). All costs are in 1999 Canadian dollars (C$1 ≈ US$0.65). Over 6.3 years, mean cost per patient in the ICD group was C$87 715 versus C$38 600 in the amiodarone group (difference C$49 115; 95% CI C$25 502 to C$69 508). Life expectancy for the ICD group was 4.58 years versus 4.35 years for amiodarone (difference 0.23, 95% CI −0.09 to 0.55), for incremental cost-effectiveness of ICD therapy of C$213 543 per life-year gained. ICD benefit was greater in patients with low left ventricular ejection fraction (<35%), and cost-effectiveness in this group was more attractive (C$108 484). Alternative extrapolations of survival benefit and costs to 12 years indicated cost-effectiveness in the range of C$100 000 to C$150 000 per life-year gained.